Hamdan Medical Journal (previously the Journal of Medical Sciences)

Table of Contents  

Organ Transplantation from the Laboratory to the Clinic

R Y Calne
Published in : Journal of Medical Sciences ; Vol 2, No 2 (2009)
DOI : 10.2174/1996327000902020039

Abstract


Organ transplantation is an extraordinary success story, developing rapidly from slow and distressing beginnings to a standard life-saving treatment now given to more than 1 million recipients worldwide.



View article in  :   PDF    

References


Schwartz R, Dameshek W. Drug induced immunologic tolerance. Nature 1959; 183: 1682-3.

Calne RY. The rejection of renal homografts. Inhibition in dogs by using 6-mercaptopurine. Lancet 1960; 1: 417-8.

Hopewell J, Calne RY, Beswick I. Three clinical cases of renal transplantation. Br Med J 1964; 1: 411-3.

Kuss R, Ourget B. An illustrated history of organ transplantation. The great Adventure of the Century. Sandoz 1992.

Calne RY. Inhibition of the rejection of renal homografts in dogs by purine analogues. Transplant Bull 1961; 28 :65-81.

Murray JE, Merrill JP, Harrison JH, Wilson RE, Dammin GJ. Prolonged survival of human kidney homografts by immunosuppressive drug therapy. New Eng J Med 1963; 268: 1315-23.

Starzl TE. Experience in Renal Transplantation, W.B. Saunders, Philadelphia and 1964, London

Starzl TE. Experience in hepatic transplantation. Philadelphia, WB Saunders 1969, pp. 45-48.

Calne RY, Sells RA, Pena JR, et al. Induction of immunological tolerance by porcine liver allografts. Nature 1969; 223: 472-6.

Calne RY, Williams R. Liver transplantation in man. Observations on technique and organization in five cases. Br Med J 1968; 4: 535-40.

Borel JF, Feurer C, Gubler HU, Stahelin H. Biological effects of cyclosporine A: A new antilymphocytic agent. Agents Actions 1976; 6: 468-75.

Kostakis AJ, White DJG, Calne RY. Prolongation of rat heart allograft survival by cyclosporin A. Int Red Commun Syst Med Sci 1977; 5: 280.

Calne RY, White DJG. Cyclosporin A - A powerful immunosuppressant in dogs with renal allografts. IRCS Med Sci 1977; 5: 595.

Calne RY, White DJG, Rolles K, Smith, DP, Herbertson BM. Prolonged survival of pig orthotopic heart grafts treated with cyclosporine A. Lancet 1978; 3: 1183-5.

Calne RY, White DJG, Thiru S, et al. Cyclosporin A in patients receiving renal allografts from cadaver donors. Lancet 1978; 2: 1323-7.

Calne RY, Rolles K, White DJ, et al. Cyclosporin A initially as the only immunosuppressant in 34 recipients of cadaveric organs: 32 kidneys, 2 pancreases, and 2 livers. Lancet 1979; 2: 1033-6.

Calne RY, Pollard SG, Jamieson NV, et al. Intestinal transplant for recurring mesenteric desmoid tumour. Lancet 1993; 342: 8-59.

Wallwork J, Williams R, Calne RY. Transplantation of liver, heart, and lungs for primary biliary cirrhosis and primary pulmonary hypertension. Lancet 1987; 2: 182-5.

Ochiai T, Sakamoto K, Nagata M, et al. Studies on FK506 in experimental organ transplants. Transplant Proc 1988; 20: 209-14

Calne RY, Collier D.St.J, Thiru S. Observations about FR900506 in primates. Transplant Proc 1987; 19: 63.

Calne RY, Collier D, Lim S, et al. Rapamycin for immunosuppression in organ allografting. Lancet 1989; 2: 227.

Starzl TE, Fung J, Jordan M, et al. Kidney transplantation under FK506. JAMA 1990; 264: 63-7.

Kohler G, Milstein C. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 1975; 256: 495-7.

Hale G, Dyer MJ, Clark MR, et al. Remission induction in non-Hodgkin lymphoma with reshaped human monoclonal antibody of Campath lH. Lancet 1988; 2: 1394-9.

Friend PJ, Rebello P, Oliveira D, et al. Successful treatment of renal allograft rejection with a humanised antilymphocyte monoclonal antibody. Transplant Proc 1995;27: 869-70.

Knechtle SJ, Vargo D, Fechner J, et al. FN18-CRM9 immunotoxin promotes tolerance in primate renal allografts. Transplantation 1997; 63: 1-6.

Calne RY, Friend PJ, Moffatt S, et al. Prope tolerance, perioperative campath IH, and lowdose cyclosporin monotherapy in renal allograft recipients. Lancet 1998; 351: 1701-2.

Calne RY, Moffatt SD, Friend PJ, et al. Campath 1H allows low-dose cyclosporin monotherapy in 31 cadaveric renal allograft recipients. Transplantation 1999; 68: 1613-6.

Watson CJ, Bradley JA, Friend PJ, et al. Alemtuzumab (CAMPATH 1H) induction therapy in cadaveric kidney transplantation-efficacy and safety at five years. Am J Transplant 2005; 5:1347-53.

Zhou Y, Phan TT, Gan Shu Uin, et al. Prolonged survival of human amnion cells in immunologically fully competent mice. Trans Int 2007; 20: 7.

Ren B, O'Brien BA, Swan MA, et al. Long-term correction of diabetes in rats following lentiviral hepatic insulin gene therapy. Diabetologia 2007; 50: 1910-20.





Add comment 





Home  Editorial Board  Search  Current Issue  Archive Issues  Announcements  Aims & Scope  About the Journal  How to Submit  Contact Us
Find out how to become a part of the HMJ  |   CLICK HERE >>
© Copyright 2012 - 2013 HMJ - HAMDAN Medical Journal. All Rights Reserved         Website Developed By Cedar Solutions INDIA